Introduction
Ofloxacin (Fig. 1) is one of the most commonly used second-generation fluoroquinolone broad-spectrum antimicrobial marketed in the form of (S)-enantiomer i.e. a levofloxacin and racemic mixture. Levofloxacin shows an 8-to 128-flod higher activity than its (R)-isomer with different in vitro bacterial strains. 1 Chiral liquid-chromatography techniques based on a ligand exchange principle are applied to the enantiomeric separation of ofloxacin on a conventional C18 column using a low concentration of copper sulfate and amino acid as a chiral mobile phase. Some papers investigated the effect of different amino acid and columns on the resolution (Rs) of the enantiomers and the results implied that the resolutions of the column were closely associated with the amino acid. [2] [3] [4] A few capillary electrokinetic chromatographic methods were published for the enantiomeric separation of ofloxacin using neutral or charged cyclodextrines (CDs) as chiral selectors. [5] [6] [7] Nevertheless, a few methods have been reported using a chiral column to separate the ofloxacin enantiomers. In particular, the use of enantioselective stationary phases (CSPs) enables a direct separation of the enantiomers without any preliminary derivation with chiral reagents.
In this article, we report on the development of an HPLC method to detect ofloxacin enantiomers using a Chiralcel OD-H column that has a cellulose carbamate derivative as CSP for the first time. The effect of organic modifiers and temperature on the resolution and the retention of ofloxacin enantiomers has been studied and the mobile-phase composition has been optimized.
Experimental
Reagents Racemic mixtures (99%) containing (S)-and (R)-ofloxacin was obtained from Sigma-Aldrich (St. Louis, MO). (S)-Ofloxacin was purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). All solvents used in the sample preparation and chromatographic separation were of HPLC grade. Methanol, 2-propanol and hexane were all supplied by Dikma Technologies (USA). Ethanol was from J. T. Baker (USA). Acetic acid and diethylamine were all from Beijing Chemical Co. (Beijing, China). Ultra-pure-water was made using a Milli-Q Ultra-pure System (Millipore, Bedford, MA).
Stock standard solutions of (R)-and (S)-ofloxacin were prepared by dissolving 10 mg of powder, accurately weighed in 10 mL methanol, obtaining a final concentration of 1000 μg/mL. These solutions were stored at -20 C. Working solutions in LC analysis were obtained by diluting the stock solutions with the LC mobile phase.
Apparatus
A Waters Alliance 2695 HPLC system coupled with a 2475 fluorescence detector (Waters Milford, MA) was used for analysis of the target compound. Data acquisition, data processing and instrument control were performed using Empower 2.0 software based on Microsoft Windows XP.
Liquid chromatography with fluorescence detection (LC-FLD)
The chromatographic separation was optimized on a chiral stationary phase Chiralcel OD-H (250 mm × 4.6 mm, 5 μm, † To whom correspondence should be addressed. E-mail: shaobingch@sina.com Rs was calculated using the following equations: Rs = 2(tR -tS)/(wR + wS), where tS and tR are the retention times of the (S)-and (R)-enantiomers, respectively, and wS and wR are the baseline peak widths of the two enantiomers.
Results and Discussion

Mobile phase optimization
It was well known that the resolutions of enantiomers based on a CSPs column were closely associated with the CSPs column, mobile-phase composites and mobile-phase additives. Firstly, two commonly used CSPs columns, such as Chiralcel OD-H and a Shiseido chiral CD-Ph, were applied to separate the ofloxacin. Typical mobile phases for CD-Ph β-cyclodextrin, such as acetonitrile-water, methanol-water, hexane-ethanol and hexane-2-propanol, were used for tests. No indication of separation was found, even upon the addition of some acid or basic additives. The commonly used mobile-phase composite for the Chiralcel OD-H column, such as hexane-ethanol and hexane-2-propanol, was applied to the enantiomeric separation of ofloxacin. There was no indication that the separation was achieved using different ratios of hexane-ethanol or hexane-2-propanol. However, after the addition of a small quantity of acetic acid as a modifier, limited separation was observed using different ratios of hexane-ethanol or hexane-2-propanol. In order to shorten the analytical time, methanol was added. The Rs values were slightly increased. Consideration for the amphoteric character of ofloxacin, diethylamine (DEA), a common additive, was often added to the mobile phase in which the analytes contained an amino basic function, but the total content of the additives remained below 0.5%, as the instruction manual recommended. When diethylamine was added, the peak tailing was reduced and Rs was enhanced, with reducing the analytical time (Fig. 2) . Based on the above considerations, mobile-phase systems containing different ratios of hexane-ethanol-methanol-acetic acid-diethylamine and hexane-2-propanol-methanol-acetic acid-diethylamine were investigated. The values of Rs indicated that baseline separation (Rs >1.20) was obtained using a mobile-phase system of hexaneethanol-methanol-acetic acid-diethylamine (70/20/10/0.45/0.05, v/v/v/v/v). The effect of the column temperature on the resolution and the retention of ofloxacin enantiomers were also studied in the range 25 -40 C on Chiralcel OD-H column. The selectivity (α) and Rs were increased with decreasing of the column temperature. At 25 C, an acceptable Rs value (1.38) with complete separation was achieved with the mobile phase consisting of hexane-ethanol-methanol-acetic acid-diethylamine (70:20:10:0.45:0.05 v/v/v/v/v) (Fig. 2(b) ).
Precision, linearity, LOQ and LOD
The precision of the method was studied for instrumental repeatability (n = 6) and intermediate precision (n = 18). The results were expressed in terms of the relative standard deviation (RSD) values for the peak area. For instrumental repeatability, the RSD values for the (S)-and (R)-enantiomers were found to be below 4.1 and 5.5%, respectively. Intermediate precisions for two enantiomers were found to be below 3.6 and 8.1%, respectively. These results indicate a good precision.
The detector response linearity was assessed by preparing six calibration sample solutions of (S)-enantiomer and (R)-enantiomer covering from 10 μg/L to 5 μg/mL, prepared in the mobile phase from the stock solution. The determination coefficients (r 2 ) of the plots obtained for both ofloxacin enantiomers (>0.99) demonstrated a good linearity. The RSD values for the slope of the standard calibration curves of (R)-ofloxacin and (S)-ofloxacin (n = 5) were 4.5 and 7.3%, respectively.
The limit of detection (LOD) and limit of quantification (LOQ) were both considered to be the concentrations that produced signal-to-noise ratios of 3 and 10, respectively. They were determined from linear regression by extrapolation of the signal-to-noise ratio as a function of the concentration. The values obtained for the LOD were 10 μg/L for (R)-ofloxacin and (S)-ofloxacin, respectively, and for LOQ they were 25 μg/L for two enantiomers.
Conclusions
In the present work, a chiral HPLC separation was developed for the determination of ofloxacin enantiomers, without derivatization, using a cellulose-based stationary phase (Chiralcel OD-H column) in the normal-phase mode. The obtained separation offered good resolution for both enantiomers (Rs = 1.38) with an analytical time of 20 min, using a mobile phase composition, hexane-ethanol-methanol-acetic acid-diethylamine (70/20/10/0.45/0.05, v/v/v/v/v) at a flow rate of 1.0 ml/min with a temperature column of 25 C. The method showed good performance regarding the linearity and instrumental repeatability. 
